Philips Affiniti 70, Diagnostic Ultrasound System Model # 795210

FDA Device Recall #Z-0284-2024 — Class II — October 9, 2023

Recall Summary

Recall Number Z-0284-2024
Classification Class II — Moderate risk
Date Initiated October 9, 2023
Status Completed
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Philips Ultrasound, Inc.
Location Bothell, WA
Product Type Devices
Quantity 7 systems

Product Description

Philips Affiniti 70, Diagnostic Ultrasound System Model # 795210

Reason for Recall

Their is the potential that diagnostic ultrasound systems operating with software version 10.0 may present a delayed image instead of a real time image.

Distribution Pattern

US: AZ, CA, CT, FL, GA, ID, IL, KY, MD, MT, NE, NV, OH, TN, TX, UT, VA OUS: Canada

Lot / Code Information

Following serial numbers operating with software version 10.0. Model 795210/UDI: (01)00884838106611/Serial Numbers: US523F1930 US918F1158 US918F1159 US723F1377 US523F1496 US523F1497 US217F0292

Other Recalls from Philips Ultrasound, Inc.

Recall # Classification Product Date
Z-1757-2024 Class II 5000 Compact Series Ultrasound Systems, Product... Mar 23, 2024
Z-0283-2024 Class II Philips EPIQ Diagnostic Ultrasound System Model... Oct 9, 2023
Z-2517-2023 Class II 3D9-3v Transducer, accessory to Philips Ultraso... Jun 30, 2023
Z-1380-2016 Class II EPIQ DIAGNOSTIC ULTRASOUND SYSTEM, Model EPIQ 5... Mar 28, 2016
Z-0596-2016 Class II Philips Lumify Diagnostic Ultrasound, Catalogue... Dec 9, 2015

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.